Investor Relations
We are pleased to report that Accreditation certificate of foreign animal drug manufacturer for Friulchem S.p.A. was issued on 12 October 2018.This certificate is an important milestone for our company and represents a serious commitment to continuous improvement as we proceed along our path.
Friulchem presentation video
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 45,000 visiting pharma professionals over three days. Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is an effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends. Friulchem S.p.A. will be exhibiting at CPhI Worldwide in …
CPhI Worldwide 2018 CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 45,000 visiting pharma professionals over three days. Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is an effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends. Friulchem S.p.A. will be …
Unione Industriali Pordenone Today, the association Unione Industriali Pordenone has published an article on Friulchem S.p.A. In their section “Imprese in evidenza”, they talk about our company and our future projects. Read here.
Friulia investe nello sviluppo di Friulchem Friulia sostiene il consolidamento finanziario di Friulchem, azienda specializzata nella trasformazione di principi attivi per la produzione di farmaci e medicinali generici in ambito umano e veterinario per conto terzi. Con un intervento di private equity del valore di 1,9 milioni di Euro, Friulia consentirà l’incremento del giro d’affari della realtà di Vivaro, …
Friulia sostiene il consolidamento finanziario di Friulchem, azienda specializzata nella trasformazione di principi attivi per la produzione di farmaci e medicinali generici in ambito umano e veterinario per conto terzi. Con un intervento di private equity del valore di 1,9 milioni di Euro, Friulia consentirà l’incremento del giro d’affari della realtà di Vivaro, grazie agli investimenti in R&D per …
A new look for Evultis In the next forthcoming CPhI China, you will be able to discover more on Evultis products and the new Joint Venture. The new collaboration in China allows Evultis to be up to date on the market situation, and propose the best solutions for its partners. Evultis 2018
CPhI China 2018 Visit CPhI China Friulchem is glad to meet you at Kerry Hotel – Club Lounge meeting room 2 for presenting its news. Contact us at friulchem@friulchem.com
Visit CPhI Japan 2018 CPhI Japan is the opportunity to meet the country’s industry leaders.This event has been the central platform for international businesses for over ten years, where decision makers from Japan and overseas connect and do business. Friulchem will attend this important event. Meet us at stand IP-14.